Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Natus Medical Inc    BABY

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Natus Medical : Natus to Present at the Thomas Weisel Partners 2007 Healthcare Conference

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/28/2007 | 02:00pm CEST

Natus Medical Incorporated (Nasdaq:BABY) today announced that Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Thomas Weisel Partners 2007 Healthcare Conference. The conference is being held at the Four Seasons Hotel in Boston, Massachusetts. Mr. Murphy is scheduled to present at 2:05 p.m. Eastern Time (11:05 a.m. PT) on Thursday, September 6, 2007.

Investors may listen to the live webcast and view a copy of the slide presentation online via the ?Investors? section of the Company's web site at http://investor.natus.com. The recorded webcast will be accessible online for at least 30 days. Attendance at the Thomas Weisel Partners 2007 Healthcare Conference is by invitation only.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments such as hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and newborn care. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories. Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy, Chief Financial Officer, 650-802-0400
InvestorRelations@Natus.com


© Business Wire 2007
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on NATUS MEDICAL INC
08/21 Natus to Present at Morgan Stanley 15th Annual Global Healthcare Conference
08/07 NATUS MEDICAL : Management's Discussion and Analysis of Financial Condition and ..
07/26 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) reported earnings of $0.34 per share ..
07/26 NATUS MEDICAL : reports 2Q loss
07/26 NATUS MEDICAL INCORPORATED (NASDAQ : BABY) Files An 8-K Results of Operations an..
07/26 NATUS MEDICAL INC : Results of Operations and Financial Condition, Financial Sta..
07/26 Natus Medical Announces Second Quarter 2017 Financial Results
07/21 ROBBINS ARROYO LLP : Is Investigating the Officers and Directors of Natus Medica..
07/21 NATUS MEDICAL : $166,099 Federal Contract Awarded to Natus Medical
07/13 Natus Medical to Hold 2017 Second Quarter Financial Results Conference Call o..
More news
News from SeekingAlpha
07/26 Natus Medical's (BABY) CEO James Hawkins on Q2 2017 Results - Earnings Call T..
07/26 Natus Medical Q2 revenues up 27%; updates guidance
07/26 Natus Medical beats by $0.01, beats on revenue
07/25 Notable earnings before Wednesday?s open
06/23 Natus Medical Incorporated (BABY) Investor Presentation - Slideshow
Financials ($)
Sales 2017 505 M
EBIT 2017 76,0 M
Net income 2017 20,8 M
Debt 2017 37 027 M
Yield 2017 -
P/E ratio 2017 51,59
P/E ratio 2018 22,11
Capi. / Sales 2017 75,5x
Capi. / Sales 2018 2,10x
Capitalization 1 077 M
Chart NATUS MEDICAL INC
Duration : Period :
Natus Medical Inc Technical Analysis Chart | BABY | US6390501038 | 4-Traders
Technical analysis trends NATUS MEDICAL INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 48,0 $
Spread / Average Target 48%
EPS Revisions
Managers
NameTitle
James B. Hawkins President, Chief Executive Officer & Director
Robert A. Gunst Chairman
Jonathan A. Kennedy Chief Financial Officer & Executive Vice President
D. Christopher Chung VP-Medical Affairs, Quality & Regulatory
Doris E. Engibous Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
NATUS MEDICAL INC-6.61%1 077
THERMO FISHER SCIENTIFIC INC.22.30%68 837
DANAHER3.89%56 180
BOSTON SCIENTIFIC CORPORATION24.32%36 896
INTUITIVE SURGICAL55.21%36 568
ROYAL PHILIPS9.34%35 087